SARAH DOWDA: Open Payments
NPI 1003514324 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,596 in 64 payments from 20 companies in 2025. Trend: 2023 $1,202 · 2024 $1,066 · 2025 $1,596
Food & beverage: $1,596
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 9 | $302 |
| PFIZER INC. | 11 | $239 |
| Otsuka America Pharmaceutical, Inc. | 8 | $203 |
| AstraZeneca Pharmaceuticals LP | 12 | $199 |
| ABIOMED | 2 | $173 |
| Biosense Webster, Inc. | 1 | $104 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $57 |
| Amgen Inc. | 3 | $46 |
| Novo Nordisk Inc | 2 | $44 |
| Phathom Pharmaceuticals, Inc. | 2 | $37 |
Products named: REXULTI, JARDIANCE, ELIQUIS, QDOT MICRO, MOUNJARO, ZEPBOUND, NURTEC ODT, PREVNAR 20.
Industry payments across CA — which companies pay providers there.
